First patient dosed in LINNET Phase 2 study of lorigerlimab in ovarian and other gynecologic cancers Clinical update on LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination ...

Clinical update on LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on anti-cancer therapies, announced today that a poster presentation of preclinical data of CS2009 ...

Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025 New gene expression signature for cancer patients to predict clinical response ...

Replimune Group, Inc.'s RP1 + OPDIVO for advanced melanoma gains FDA Priority Review. PDUFA date: July 22, 2025. Read more on REPL stock prospects.

KHAN YOUNIS, Gaza Strip (AP) — Nearly seven months pregnant, Yasmine Siam couldn’t sleep, living in a crowded tent camp in Gaza and shaken often by Israeli bombardment. She couldn’t find pro ...

KHAN YOUNIS, Gaza Strip (AP) — Nearly seven months pregnant, Yasmine Siam couldn’t sleep, living in a crowded tent camp in Gaza and shaken often by Israeli bombardment. She couldn’t find proper food ...

KHAN YOUNIS, Gaza Strip (AP) — Israel’s military campaign in the Gaza Strip has made pregnancy and childbirth more dangerous for Palestinian women and their babies. It’s become worse since ...

KHAN YOUNIS, Gaza Strip (AP) — Nearly seven months pregnant, Yasmine Siam couldn’t sleep, living in a crowded tent camp in Gaza and shaken often by Israeli bombardment. She couldn’t find pro ...

“Even the basics are impossible,” Brown said. Under the blockade, over half the medicines for maternal and newborn care have run out, including ones that control bleeding and induce ...